Seaweed supplement shows promise for cancer-related fatigue in small pilot trial

NCT ID NCT06295588

Recruiting now Symptom relief Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether taking a seaweed supplement called fucoidan for 8 to 16 weeks can reduce fatigue and inflammation in cancer survivors. Researchers will enroll 40 adults who have completed cancer treatment within the last 10 years and still feel tired. The main goal is to see if the study is feasible, but they will also measure changes in fatigue, frailty, and blood markers of inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fucoidan (a seaweed supplement)
What this could lead to: If it works, this could point toward a natural supplement to ease fatigue and inflammation in cancer survivors.
What could go wrong: This is a small, early pilot study with only 40 people. It's testing feasibility, not yet effectiveness, and results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FATIGUE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fatigue Inflammation inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FATIGUE INFLAMMATION

Contacts and locations

Locations

University of Rochester Medical Center
RECRUITING

Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.